Status:

WITHDRAWN

The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications

Lead Sponsor:

Yale University

Collaborating Sponsors:

Ono Pharmaceutical Co. Ltd

Conditions:

Coagulopathy

Cardiovascular Complication

Eligibility:

All Genders

18+ years

Phase:

PHASE1

PHASE2

Brief Summary

The primary aim of this study is to determine whether Camostat mesylate reduces SARS-COV-2 associated coagulopathy. Additional aims are to determine the effect of Camostat mesylate on SARS-COV-2 assoc...

Detailed Description

The trial is in-patient only. Participants are identified by the hospital physicians and house staff, and contacted by research study personnel. Potential participants fulfilling inclusion criteria an...

Eligibility Criteria

Inclusion

  • . Positive COVID-19 test result.
  • Diagnosis of COVID-19 associated coagulopathy and cardiac complications based on D-Dimer, fibrinogen, TnT, CTPE, ischemic EKG changes
  • Provision of informed consent. In patients with altered mental status consents can be obtained from the power of attorney.
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male or female, age 18 or older
  • Diagnosed with hypoxia requiring intubation or positive air pressure.
  • Diagnose with DVT/PE by ultrasound and CTPE and/or
  • Elevated D-Dimer and/or
  • Greater than 2-fold increase in TnT
  • Ischemic EKG changes with ST depression or elevation more than 1 mm in 2 consecutive leads
  • Ability to administer oral medication.

Exclusion

  • GFR\<30 mL/min
  • Severe bleeding requiring blood transfusion of drop of 5% in HCT.
  • Pregnancy or lactation
  • Known allergic reactions to components of Camostat mesylate.
  • Subjects under age 18

Key Trial Info

Start Date :

November 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2021

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04435015

Start Date

November 1 2021

End Date

December 31 2021

Last Update

May 18 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications | DecenTrialz